The release of the snapshot containing the respective simulations can be found here:
https://github.com/Open-Systems-Pharmacology/Rifampicin-Triazolam-DDI/releases/tag/v1.2

The rifampicin-triazolam interaction was evaluated using one clinical DDI study ([Villikka 1997](#4-references)).



| DataID | Enzyme | Perpetrator / victim   | Study design                                                 | Comments | Clinical study                 |
| ------ | ------ | ---------------------- | ------------------------------------------------------------ | -------- | ------------------------------ |
| 1004   | CYP3A4 | Rifampicin / triazolam | Rifampicin: 600 mg QD for 5 days<br />Triazolam: 0.5 mg po single dose, 17 hours after the last rifampicin dose |          | [Villikka 1997](#4-references) |


